Bayer's Levitra approved from EC

Published: 2003-03-12 07:00:00

Updated: 2003-03-12 07:00:00

Bayer and GlaxoSmithKline announced on March 7 that they have received marketing authorization from the European Commission for Levitra (vardenafil HCl) for the treatment of male erectile dysfunction. The decision follows a positive opinion by the Europe Committee for Proprietary Medicinal Produc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK